179 related articles for article (PubMed ID: 19011184)
21. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer.
van Westreenen HL; Westerterp M; Bossuyt PM; Pruim J; Sloof GW; van Lanschot JJ; Groen H; Plukker JT
J Clin Oncol; 2004 Sep; 22(18):3805-12. PubMed ID: 15365078
[TBL] [Abstract][Full Text] [Related]
22. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Clark PB; Soo V; Kraas J; Shen P; Levine EA
Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomography for staging and management of malignant melanoma.
Prichard RS; Hill AD; Skehan SJ; O'Higgins NJ
Br J Surg; 2002 Apr; 89(4):389-96. PubMed ID: 11952577
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
Bastiaannet E; Uyl-de Groot CA; Brouwers AH; van der Jagt EJ; Hoekstra OS; Oyen W; Verzijlbergen F; van Ooijen B; Thompson JF; Hoekstra HJ
Ann Surg; 2012 Apr; 255(4):771-6. PubMed ID: 22367443
[TBL] [Abstract][Full Text] [Related]
25. Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study.
Jouvet JC; Thomas L; Thomson V; Yanes M; Journe C; Morelec I; Bracoud L; Durupt F; Giammarile F; Berthezene Y
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):176-85. PubMed ID: 23331931
[TBL] [Abstract][Full Text] [Related]
26. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma.
Veit-Haibach P; Vogt FM; Jablonka R; Kuehl H; Bockisch A; Beyer T; Dahmen G; Rosenbaum S; Antoch G
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):910-8. PubMed ID: 19156409
[TBL] [Abstract][Full Text] [Related]
28. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Haacke EM; Hu J
J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065
[TBL] [Abstract][Full Text] [Related]
29. The role of FDG-PET-CT is limited in initial staging of nodal metastasis for thin cutaneous melanoma.
Cheng D; McNicoll CF; Kirgan D; Jones MS; Rivera MR; Doyle GM; De Guzman MD; Baynosa J; St Hill CR
Am J Surg; 2021 Apr; 221(4):737-740. PubMed ID: 32354604
[TBL] [Abstract][Full Text] [Related]
30. Comparison of 18F-FDG PET/CT with bone scintigraphy for detection of bone metastasis: a meta-analysis.
Cheng X; Li Y; Xu Z; Bao L; Li D; Wang J
Acta Radiol; 2011 Sep; 52(7):779-87. PubMed ID: 21712464
[TBL] [Abstract][Full Text] [Related]
31. A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy.
Finkelstein SE; Carrasquillo JA; Hoffman JM; Galen B; Choyke P; White DE; Rosenberg SA; Sherry RM
Ann Surg Oncol; 2004 Aug; 11(8):731-8. PubMed ID: 15249335
[TBL] [Abstract][Full Text] [Related]
32. A review of the literature for whole-body FDG PET in the management of patients with melanoma.
Schwimmer J; Essner R; Patel A; Jahan SA; Shepherd JE; Park K; Phelps ME; Czernin J; Gambhir SS
Q J Nucl Med; 2000 Jun; 44(2):153-67. PubMed ID: 10967625
[TBL] [Abstract][Full Text] [Related]
33. No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma.
Bikhchandani J; Wood J; Richards AT; Smith RB
Head Neck; 2014 Sep; 36(9):1313-6. PubMed ID: 23956077
[TBL] [Abstract][Full Text] [Related]
34. Guidelines for lymphoscintigraphy and F18 FDG PET scans in melanoma.
Uren RF; Howman-Giles R; Chung D; Thompson JF
J Surg Oncol; 2011 Sep; 104(4):405-19. PubMed ID: 21858836
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
[TBL] [Abstract][Full Text] [Related]
36. Role of FDG-PET in the assessment of survival prognosis in melanoma.
Pleiss C; Risse JH; Biersack HJ; Bender H
Cancer Biother Radiopharm; 2007 Dec; 22(6):740-7. PubMed ID: 18158764
[TBL] [Abstract][Full Text] [Related]
37. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
[TBL] [Abstract][Full Text] [Related]
38. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
39. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.
Kyzas PA; Evangelou E; Denaxa-Kyza D; Ioannidis JP
J Natl Cancer Inst; 2008 May; 100(10):712-20. PubMed ID: 18477804
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.
Chang MC; Chen JH; Liang JA; Lin CC; Yang KT; Cheng KY; Yeh JJ; Kao CH
Acad Radiol; 2012 Mar; 19(3):349-57. PubMed ID: 22173321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
